CLARITIN-D Drug Patent Profile
✉ Email this page to a colleague
When do Claritin-d patents expire, and when can generic versions of Claritin-d launch?
Claritin-d is a drug marketed by Bayer Healthcare Llc and is included in two NDAs.
The generic ingredient in CLARITIN-D is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Claritin-d
A generic version of CLARITIN-D was approved as loratadine; pseudoephedrine sulfate by PERRIGO PHARMA INTL on January 30th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLARITIN-D?
- What are the global sales for CLARITIN-D?
- What is Average Wholesale Price for CLARITIN-D?
Summary for CLARITIN-D
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 27 |
Drug Sales Revenues: | Drug sales revenues for CLARITIN-D |
What excipients (inactive ingredients) are in CLARITIN-D? | CLARITIN-D excipients list |
DailyMed Link: | CLARITIN-D at DailyMed |
Recent Clinical Trials for CLARITIN-D
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Andover Research Eye Institute | Phase 4 |
National Cancer Institute (NCI) | Early Phase 1 |
Rutgers, The State University of New Jersey | Early Phase 1 |
Pharmacology for CLARITIN-D
Drug Class | alpha-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists |
US Patents and Regulatory Information for CLARITIN-D
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | CLARITIN-D | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019670-002 | Nov 27, 2002 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Healthcare Llc | CLARITIN-D 24 HOUR | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 020470-002 | Nov 27, 2002 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CLARITIN-D
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | CLARITIN-D | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019670-002 | Nov 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Healthcare Llc | CLARITIN-D | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019670-002 | Nov 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CLARITIN-D
See the table below for patents covering CLARITIN-D around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H03502696 | ⤷ Sign Up | |
Portugal | 73200 | PROCESS FOR PREPARING NOVEL ANTIHISTAMINES | ⤷ Sign Up |
Denmark | 469485 | ⤷ Sign Up | |
Spain | 8300779 | ⤷ Sign Up | |
Japan | H0631220 | ⤷ Sign Up | |
Japan | 2511412 | ⤷ Sign Up | |
Japan | H0572910 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CLARITIN-D
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1110543 | 08C0004 | France | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
0152897 | SPC/GB01/012 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
0152897 | 2001C/013 | Belgium | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
0152897 | C00152897/01 | Switzerland | ⤷ Sign Up | FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |